Severe bilateral pleuropneumonia caused by Legionella sainthelensi: a case report.
Case report
Legionella sainthelensi
Legionnaires’ disease
PCR syndromic testing
bilateral pleuropneumonia
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
17 Sep 2021
17 Sep 2021
Historique:
received:
20
02
2021
accepted:
01
09
2021
entrez:
18
9
2021
pubmed:
19
9
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Legionella spp. are ubiquitous freshwater bacteria responsible for rare but potentially severe cases of Legionnaires' disease (LD). Legionella sainthelensi is a non-pneumophila Legionella species that was first isolated in 1980 from water near Mt. St-Helens (USA). Although rare cases of LD caused by L. sainthelensi have been reported, very little data is available on this pathogen. We describe the first documented case of severe bilateral pleuropneumonia caused by L. sainthelensi. The patient was a 35-year-old woman with Sharp's syndrome treated with long-term hydroxychloroquine and corticosteroids who was hospitalized for an infectious illness in a university hospital in Reunion Island (France). The patient's clinical presentation was complicated at first (bilateral pneumonia, multiloculated pleural effusion, then bronchopleural fistula) but her clinical condition eventually improved with the reintroduction of macrolides (spiramycin) in intensive care unit. Etiological diagnosis was confirmed by PCR syndromic assay and culture on bronchoalveolar lavage. To date, only 14 documented cases of L. sainthelensi infection have been described worldwide. This pathogen is difficult to identify because it is not or poorly detected by urinary antigen and molecular methods (like PCR syndromic assays that primarily target L. pneumophila and that have only recently been deployed in microbiology laboratories). Pneumonia caused by L. sainthelensi is likely underdiagnosed as a result. Clinicians should consider the possibility of non-pneumophila Legionella infection in patients with a compatible clinical presentation when microbiological diagnostic tools targeted L. pneumophila tested negative.
Sections du résumé
BACKGROUND
BACKGROUND
Legionella spp. are ubiquitous freshwater bacteria responsible for rare but potentially severe cases of Legionnaires' disease (LD). Legionella sainthelensi is a non-pneumophila Legionella species that was first isolated in 1980 from water near Mt. St-Helens (USA). Although rare cases of LD caused by L. sainthelensi have been reported, very little data is available on this pathogen.
CASE PRESENTATION
METHODS
We describe the first documented case of severe bilateral pleuropneumonia caused by L. sainthelensi. The patient was a 35-year-old woman with Sharp's syndrome treated with long-term hydroxychloroquine and corticosteroids who was hospitalized for an infectious illness in a university hospital in Reunion Island (France). The patient's clinical presentation was complicated at first (bilateral pneumonia, multiloculated pleural effusion, then bronchopleural fistula) but her clinical condition eventually improved with the reintroduction of macrolides (spiramycin) in intensive care unit. Etiological diagnosis was confirmed by PCR syndromic assay and culture on bronchoalveolar lavage.
CONCLUSIONS
CONCLUSIONS
To date, only 14 documented cases of L. sainthelensi infection have been described worldwide. This pathogen is difficult to identify because it is not or poorly detected by urinary antigen and molecular methods (like PCR syndromic assays that primarily target L. pneumophila and that have only recently been deployed in microbiology laboratories). Pneumonia caused by L. sainthelensi is likely underdiagnosed as a result. Clinicians should consider the possibility of non-pneumophila Legionella infection in patients with a compatible clinical presentation when microbiological diagnostic tools targeted L. pneumophila tested negative.
Identifiants
pubmed: 34535079
doi: 10.1186/s12879-021-06651-1
pii: 10.1186/s12879-021-06651-1
pmc: PMC8447505
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
966Informations de copyright
© 2021. The Author(s).
Références
Clin Infect Dis. 2004 Dec 1;39(11):1734-7; author reply 1737-8
pubmed: 15578385
Genome Announc. 2018 Feb 1;6(5):
pubmed: 29437115
Res Microbiol. 1990 May;141(4):453-63
pubmed: 2399367
J Clin Microbiol. 1998 Jun;36(6):1560-7
pubmed: 9620377
Euro Surveill. 2017 Jul 6;22(27):
pubmed: 28703097
J Antimicrob Chemother. 2014 Sep;69(9):2354-60
pubmed: 24827889
Int J Antimicrob Agents. 2017 Nov;50(5):684-689
pubmed: 28782709
J Clin Microbiol. 2015 Jul;53(7):2180-7
pubmed: 25926494
Appl Environ Microbiol. 1984 Feb;47(2):369-73
pubmed: 6712210
Appl Environ Microbiol. 1991 Oct;57(10):2921-7
pubmed: 1746954
Clin Infect Dis. 2020 May 23;70(11):2428-2431
pubmed: 31617567
J Am Geriatr Soc. 1999 May;47(5):547-52
pubmed: 10323647